Vericiguat Modulates Osteoclast Differentiation and Bone Resorption via a Balance between VASP and NF-κB Pathways

Figure 10

Validation of the effects of Vericiguat on OVX-induced bone loss in vivo indicated by histological analysis. (a) Representative images of H&E staining and TRAP staining within the selected metaphyseal region from the sham group, OVX group, low-dose group, and high-dose group (). (b) The number and area of TRAP⁺ cells per bone surface were quantified. , , , and . .

(a)

(b)